Sapanas

Global and US EHR-EMR Market: Information by Components (Software, Services & Consulting and Hardware), Application (Specialty Based and General Applications), Mode of Delivery (On-Premise Model and Cloud-Based), End User (Hospital & Clinics, Ambulatory Care and Diagnostic Centers) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

Global and US EHR-EMR Market Outlook

Electronic health record (EHR)/electronic medical record (EMR) is defined as an electronic record of patient medical history that contains all relevant administrative, clinical and other miscellaneous data of a patient under a healthcare provider. Market Research Future (MRFR) has published a research report about the global and US global and US EHR-EMR market Size that observes prosperity for this market at 5.82% CAGR during the forecast period between 2018 and 2027. By value, the market has been figured to be worth USD 42,427.27 MN by the end of the forecast period.

The critical factor for the global and US EHR-EMR market growth is increasing adoption of EHRs/EMRs for increased efficiency of patient data retrieval and storage. Other important factors enabling the market growth include rising government initiatives for the maintenance of EHRs, fewer medical errors during diagnosis or treatment process, and clinical benefits associated with applications of EHR/EMRs in medical settings. However, the market growth can get hampered due to data security concerns, need for training, and the implementation process that is complex as well as expensive.

Global and US EHR-EMR Market Segmentation Analysis

The global and US EHR-EMR market segmentation has segmented the market into application, component, end-user, mode of delivery, and region. The application-based segmentation segments this market into cardiology, neurology, oncology, radiology, specialty based, and others. In the context of component, the market has been segmented into hardware, software, and services & consulting.  

Regarding end-user, the market has been segmented into ambulatory care, diagnostic centers, hospitals, and others. Based on the mode of delivery, the market has been segmented into the cloud-based model and the on-premise model.

Global and US EHR-EMR Market Regional Analysis

The regional segmentation of the global and US EHR-EMR market segments the market into the regional markets, namely Asia Pacific, Europe, The Americas (North America & South America), and Rest-of-the-World (RoW). The Americas region holds the majority share in the global market. North America is a bigger market than South America due to the availability of advanced medical facilities and huge investment in medical research. The USA has a strong presence of many market leaders as well as a thriving healthcare sector. Due to technological advancement, the healthcare sector is adopting the advanced information technology (IT) technology. Increasing demand for advanced healthcare is also contributing to the market growth. Canada and Mexico also have the scope of becoming important country-specific markets. In South America, the same can be said for Argentina and Brazil.    

During the forecast period, the Asia Pacific region can emerge as the most significant regional market, growing at 6.77% CAGR. Japan is the largest country-specific market in this region. Developing countries in the Asia Pacific region are untapped markets that can be lucrative due to the high density of population in China and India. Therefore, the market in this region is growing slowly but steadily due to the rapid digitization of healthcare and growing healthcare reforms. Other factors contributing to the market growth include rising geriatric population, subsequent presence of a significant as well as growing patient pool, and increasing awareness regarding EHR as well as EMR. Other important country-specific markets in the Asia Pacific region are Australia and South Korea, followed by the remaining countries of this region.

Europe can rise as an important regional market due to the same reasons as in North America. Due to technological advancement, Western Europe is a bigger and more lucrative market compared to Eastern Europe. The strongest economies in this region that can suitable markets are France, Germany, and the UK.

In the MEA region, the market is small due to the lack of skilled professionals and limited availability of technology. However, the countries of the Middle East have better healthcare facilities compared to Africa.

Global and US EHR-EMR Market Key Players

The key players in the global and US EHR-EMR market include Advanced Data Systems Corporation (USA), Allscripts Healthcare Solutions (USA), Agastha Inc (USA), Advanced MD Inc. (USA), Athenahealth Inc. (USA), Cerner Corporation (USA), eClinicalWorks (USA), Epic Systems (USA), GE Healthcare (USA), Koninklijke Philips N.V. (Netherlands), Meddbase (Medical Management Systems Ltd) (UK), and Medical Information Technology Inc. (USA).

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/global-ehr-emr-market-775

Global and US EHR-EMR Industry News

NextGen Healthcare has launched its Behavioral Health Suite, a comprehensive, EHR solution. Behavioral Health Suit gives healthcare providers access to a single, integrated physical, and behavioral health record to treat patients. 6 JUNE 2019

Cerner set to provide additional interface support to the Department of Veterans Affairs' Office of Electronic Health Record Modernization under a four-year, $139.9 MN task order. 5 JUNE 2019

Global Cell Isolation Market Size, Growth and Indusrty Analysis by Product (Consumables and Instruments), Cell Type (Human Cells and Animal Cells), by Technique (Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation and Filtration-Based Cell Isolation), by Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics and Therapeutics), by End User (Research Laboratories and Institutes, Biotechnology and Biopharmaceutical Companies, Cell Banks and Hospitals and Diagnostic Laboratories) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2023

Cell Isolation Market – Overview

Cell Isolation Market Growth is expected to register a CAGR of 17.1% during the forecast period and reach USD 10,567.4 million by 2023.

The escalated level of emphasis on biotechnological research is encouraging the growth of cell isolation market. Reports that appraise the healthcare industry have been made accessible by Market Research Future, which produces reports on several industry verticals that examine the market growth and prospects.

The cost-effective benefits harnessed from the use of cell isolation techniques is expected to be a major factor motivating the development of the market in the coming years. The use of cell isolation for applications such as microarray hybridization, biomarker identification, and genetic analysis is expected to bolster the market progress in the approaching period.

Cell Isolation Market Segmental Analysis

The segmental analysis of the cell isolation market is segmented on the basis of cell type, product, end-user, technique, application, and region.  Based on the product, the cell isolation market is segmented into instruments and consumables. The segmentation of the cell isolation market report based on cell type comprises of animal cells and human cells. Based on the technique, the cell isolation market is segmented into surface marker-based cell isolation, centrifugation-based cell isolation, and filtration-based cell isolation. Based on application, the market for cell isolation is segmented into cancer research, biomolecule isolation, stem cell research, in-vitro diagnostics, tissue regeneration, and therapeutics. On the basis of end-user, the cell isolation market is segmented into biotechnology & biopharmaceutical companies, research laboratories & institutes, cell banks, and hospitals & diagnostic laboratories. On the basis of regions, the cell isolation market is segmented into the Americas, Europe, Asia Pacific, Africa, and the Middle East.

Cell Isolation Market Regional Analysis     

The regional examination of the cell isolation market comprises of regions such as the Americas, Europe, Asia Pacific, Africa, and the Middle East. The Americas region is in charge of the principal segment of the overall market presently. The growing incidence of chronic diseases, mounting expenses in R&D activities directed by healthcare organizations and government bodies along with the growing demand for proper treatment options, are motivating the regional market. Additionally, the region is also technologically progressive, and emerging countries in the region possess considerably established healthcare sectors which are at the forefront of pioneering research and technology. In the meantime, the Asia Pacific is likely to improve at a vigorous CAGR of 17.7% throughout the forecast period. The incidence of an enormous population with a substantial patient pool as compared to other regions and the continuing initiatives presented by the government to restructure the healthcare sector is projected to motivate the market. Nations such as Singapore, Australia, and Malaysia, among others, are the greatest lucrative markets in the region and include large patient pools, increased amount of geriatric population and quickly improving healthcare facilities. The market is controlled by the absence of appropriate capital, among other factors. Though, a supportive regulatory framework concerning biotechnology research is anticipated to lift market growth.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/cell-isolation-market-6193

Cell Isolation Market Competitive Analysis

The growth of the market is influenced by the presence of factors that are stimulating the growth of the market. The need to create a sustainable competitive advantage has accelerated the progress of the market in the forecast period. The diversified consumer tastes and trends in the market are anticipated to lead to an escalated development rate in the market. The use of strategic tools to further the development of the market in the coming years. The competitors have adopted diversified plans to increase their chances for success in the market. The creation of great competitive advantages is expected to aid in the development of the market. A substantial ascent in the number of promoters in the market is anticipated to shape a beneficial state of activities for the growth of the market in the forecasted period. The access to vital planned prospects imperative to the resultant stabilization of inflation is likely to produce a promising option for advancement in the forthcoming years.

The central players shaping the cell isolation market comprise of Becton, Dickinson & Company, STEMCELL Technologies, GE Healthcare, Beckman Coulter, Merck KGaA., TERUMO Corporation, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Miltenyi Biotec, F.Hoffman-La Roche AG, and others.

Global Augmented Reality in Healthcare Market Report, Trends, Growth, Size and Industry Analysis by Component (Hardware, Software), Device Type (Head-Mounted Display), Application (Fitness Management) – Forecast till 2023

Augmented Reality in Healthcare Market Overview

MRFR has asserted that AR in Healthcare Market growth is likely to achieve a valuation of USD 1.32 Bn at a dynamic CAGR of 23% by 2023.

The application of augmented reality in healthcare is still in its nascent stage but has shown signs of potentials to improve clinical outcomes. Market Research Future (MRFR) has thoroughly studied the trends and patterns governing the global augmented reality in the healthcare market over the forecast period of 2017-2023 in an extensive study. 

The application of augmented reality in healthcare has uncovered many new opportunities in the healthcare sector. Augmented reality in healthcare can assist doctors in diagnosing, treating, and performing surgeries with enhanced efficiency. The growth of the market stems from the increasing penetration of smart connected devices in the healthcare sector. Moreover, the rise in surgeries using laparoscopy, endoscopy, catheterized intervention has further paved d the way of the expansion of the market. The medical application of augmented reality is being vigorously studied by researchers which coupled with high investment from various governments is expected to propel the market. Advances in advances in camera and sensor technology and AR-focused software research is likely to expedite the growth of the market in the coming years. Other factors contributing to the market growth include high healthcare expenditure and application of augmented reality in medical training, pharmacy benefit management, and patient education. 

On the other hand, lack of proper infrastructure to incorporate augmented reality in healthcare, especially in developing countries is likely to hinder the growth of the market. Additionally, lack of technical know-how and reluctance among medical practitioners to adopt new technologies might constrain the growth of the market over the forecast period. Moreover, high costs associated with it, limited functionality, and perception problems are other bottlenecks to the growth of the market. 

Augmented Reality in Healthcare Market Segmentation

Global augmented reality in healthcare market has been segmented based on device type, component, and application. 

By device, the augmented reality in healthcare market has been segmented into handheld device, head-mounted display, and others. 

By component, the augmented reality in healthcare market has been segmented into software, hardware, and others. 

By application, the augmented reality in healthcare market has been segmented into medical training, fitness management, and education, among others. 

Augmented Reality in Healthcare Market Regional Analysis

By region, the augmented reality in healthcare market has been segmented into North America, Asia Pacific (APAC), Europe, and Rest-of-the-World (RoW). 

North America is the largest augmented reality in healthcare market share. A robust healthcare infrastructure in the region supports the growth of the market. Moreover, the region is a frontrunner in the adoption of latest technologies due to which augmented reality has gained widespread acceptance among healthcare professionals. High healthcare expenditure and technological advances in the field has further supported the market growth. Moreover, the presence of various market players in the region favors market growth.

Europe is an important revenue pocket for the augmented reality in healthcare market. Increasing healthcare expenditure along with changing healthcare policies is expected to foster the growth of the market. 

The APAC augmented reality in healthcare market report is likely to be driven by rapid technological adoption in the developing economies of the region. Moreover, fast track economic progress and improvements in healthcare infrastructure have the potential to trigger growth within the market. The APAC market is estimated to register the highest CAGR over the forecast period. 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/augmented-reality-in-healthcare-market-5236

Augmented Reality in Healthcare Market Competitive Landscape

Osterhout Design Group (U.S.), Virtually Better (U.S.), DAQRI (U.S.), Blippar (U.K), VirtaMed (Switzerland), Wikitude GmbH (Austria), Microsoft Corporation (U.S.), CAE Healthcare (U.S.), Google LLC. (U.S.), Augmedix (U.S.), Oculus VR (U.S.), Magic Leap, Inc. (U.S.), HTC (Taiwan), Philips Healthcare (Netherlands & U.S.), 3D Systems (U.S.), Medical Realities (U.K), Mindmaze (Switzerland), Atheer (U.S.), Siemens Healthineers (Germany) are the distinguished companies in augmented reality in healthcare market. 

Augmented Reality in Healthcare Industry Updates

March 2019 - Koninklijke Philips N.V., a Dutch company dedicated to creating the future of healthcare, and Microsoft Corporation, the global technology giant, have jointly developed an augmented reality concept for image-guided minimally invasive surgeries. The concept is based on Philips’ Azurion image-guided therapy platform and Microsoft’s HoloLens 2 holographic computing platform. 

Click here to read more reports on Healthcare IT

Cell Therapy Market Analysis:

Global cell therapy market size has substantial scope for growth and it can surpass a valuation of USD 20,217 million with an impressive CAGR of 22.36% between 2018 and 2023. The time frame has been discussed by Market Research Future (MRFR) and makes sure the analysis gets a solid ground. The global market for cell therapy is expecting to gain from a growing awareness among the people. Government initiatives and private investors are going to create more awareness and this would expand the market reach. Increasing investment capacity among patients can inspire better market take. In addition, the market is witnessing a strong influx of investment for the research and development sector where researchers are trying to find a cure for chronic diseases. On the other hand, the market for cell therapy may find the regulations in various countries as hurdles, which can lessen the rate of Cell Therapy Market Growth.

Cell Therapy Market Segmentation

Cell Therapy Market Report can be studied by having it segmented by type, product, technique, technology, cell source, application, and end user.

By type, the cell therapy market can be assessed on the basis of autologous and allogeneic. The autologous segment has the lead and it can surpass a valuation of USD 11,554.67 million by the end of 2023. The allogeneic segment has a scope to achieve a CAGR of 22.85% between 2018 to 2023.

By product, the cell therapy market can be segmented into Equipment, Consumables (Vessel/Media/Serum/Reagent), and Software & Other Services.

By technique, the cell therapy market has a firm foundation in a segmentation that includes Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, and Chondrocyte Cell Therapy.

By technology, the cell therapy market includes viral vector technology, cell immortalization technology, and genome editing technology.

By cell source, the cell therapy market encompasses bone marrow, adipose tissue, and umbilical cord blood-derives cells.

By application, the cell therapy market can be studied by oncology, cardiovascular diseases, orthopedic, and wound healing.

By end user, the cell therapy market can be segmented into hospitals & clinics, regenerative medicine centers, and research institutes.

Cell Therapy Market Regional Analysis

Better technological support in the Americas is going to keep the region ahead of others during the forecast period. This is primarily due to the investment made in the US and Canada by top-class companies. Robust infrastructure and awareness regarding the process would ensure that the regional Cell Therapy Market gains better growth opportunities. It has a promise to grow with 21.45% CAGR, which would be bolstered mostly by North America. In Europe, the market scenario is quite favorable. With countries like the UK, France, Germany, Russia, and others, the regional market has a better growth opportunity and it could surpass a valuation of USD 6,357.79 million by 2023. It is increasingly becoming popular to fight against various diseases like cancer and others.

In the Asia Pacific region, this growth would be substantial as several countries like China, India, Japan, and Australia would make significant contributions. This is to develop its healthcare sector.

Cell Therapy Market Competitive Analysis:

Players with huge market potential to transform the Global Cell Therapy Industry are Vericel Corporation, Osiris Therapeutics, Inc, Mesoblast Ltd, NuVasive, Inc., JCR Pharmaceuticals Co., Ltd, RTI Surgical Holdings, Inc., Pharmicell Co., Ltd, Holostem Terapie Avanzate S.r.l., AlloSource, Medipost Co., Ltd, and others. These companies are making a difference in the market by launching strategic moves that can inspire better market growth. Their initiatives get reflected often in the way they are implementing mergers, acquisitions, and other tactical changes.

In December 2019, BiologIC Technologies announced that they are planning to democratize the process of manufacturing therapies like CAR-T that would come with a factory-in-a-box able to run multiple cell therapy workflows. This would also involve 3D printing technology.

Click here to read more reports on Life Science

Radiotherapy Market Analysis

Radiotherapy or Radiation therapy refers to treating conditions, such as cancer and non-cancerous tumors, thyroid, and disorders related to the blood using high-energy rays. It is largely used in cancer treatment and less commonly in the procedures of thyroid disease, blood disorders, and non-cancerous growths. Owing to its proven efficacy in the cancer treatments, radiotherapy witnesses a massive uptake.

Subsequently, this helps to increase the size of its market. Further, technological advancements in medical science & biotechnology that have improved the outlook for cancer treatments are escalating the market on the global platform, controlling the spread of the disease sufficiently.

According to a leading research firm, Market Research Future (MRFR), the global Radiotherapy Industry growth is expected to register a CAGR of 4.7% during the forecast period of 2019 to 2025. In 2016, the market had valued at 4.5 MN, which indicates that the market is expected to achieve almost a double-fold growth over the next six years.

Cancer cases are increasing pervasively, becoming a paramount concern, globally. Improving economy that is increasing the access to quality care, is on the other hand, increasing the access to the modern life that is leading to the growing addictions, such as tobacco and alcoholism, a dominant risk factor developing cancer cells and tumors.

Additionally, increasing per capita healthcare expenditures, increasing population, exposures to harmful radiation, heredity reasons, and genetic mutations are some of the key factors driving the growth of the radiotherapy market. Increasing governmental initiatives are supporting the growth of the market, spreading awareness about cancer and its treatments.

On the flip side, high costs associated with the radiotherapy, long approval time for the clinical trials along with the adverse effects associated with therapy are obstructing the market growth. Nevertheless, unavailability of comprehensive procedures, especially in the developing regions, are expected to support the growth of the market, offering plenty of growth opportunities to the market players. Also, substantial investments in the R&D to bring more novelty and betterments in the radiology presage the broad scope for the market to evolve further over the review period. 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/1526

Global Radiotherapy Market – Segmentations

The report is segmented into three key market dynamics to widen the scope of understanding, 

By Treatment Type : Proton Therapy & X-rays and External Beam Radiotherapy (Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Radio Surgery, 3D Conformal Radiation Therapy, Tomotherapy, and Stereotactic Body Radiation Therapy.), others.

By Application: Breast Cancer, Prostate Cancer, Lung Cancer, and others.

By Regions: Europe, North America, Asia Pacific, and the Rest-of-the-World. 

Global Radiotherapy Market – Regional Analysis

North America would continue with its leading position in the global Radiotherapy market, slicing the largest market share. Majorly supported by the US, the growth in the market is fostered by the increasing prevalence of various types of cancer and thyroid as a result of the consequences of the wrong lifestyle, in the region. Moreover, technological advances, coupled with the increasing healthcare expenditure, support the growth of the regional market.

Radiotherapy market analysis in the European region is expected to account for the second-largest market, following the North American market closely. Factors boosting the regional market growth include technological advancement and the augmented adoption of radiotherapy to treat the growing cases of cancer occurrences.

The Asia Pacific region, heading with the improving economic conditions that are rapidly increasing the access to the quality of healthcare, is rapidly emerging as a profitable market for radiotherapy. Moreover, the increasing number of cancer patients in the region, alongside the advancements in medical technology, drives the market growth in the region.

Global Radiotherapy Market – Competitive Analysis

Highly competitive, the radiotherapy market appears to be fragmented, characterized by the presence of a number of well-established players. These players incorporate strategic initiatives, such as acquisition, collaboration, expansion, and technology launch, to gain a competitive advantage in the market. 

Players increasingly invest in R&D to develop a cost-effective product portfolio. They seek expansion through various strategic initiatives. They tap the growing markets for expansions and strive to address the critical needs of the market with a broad range of effective solutions and comprehensive workflow.

Major Players:

Players leading the global Radiotherapy market include Siemens (Germany), Varian (India), GE Healthcare (UK), Cardinal Health (US), Nordion (CA), Isoray (US), View ray (US), Fuji Holdings (Japan), Philips Healthcare (US), Shimadzu Corporation (Japan), and Hologic (US) among others.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/radiotherapy-market-1526

Industry/ Innovation/Related News:

January 14, 2019 --- MIM Software Inc. (the US), a leading global provider of medical imaging software solutions in the fields of radiation brachytherapy, announced the receiving of FDA 510(k) clearance for its molecular radiotherapy (MRT) dosimetry. This effective form of therapy uses radiopharmaceuticals such as Lutathera (Lu-177 DOTATATE) and Azedra (I-131 iobenguane) to target tumors based on specific receptors.

DNA Sequencing Market Scenario

Market Research Future (MRFR) postulates that the global DNA sequencing market is predicted to demonstrate a CAGR of 17.64% during the forecast period (2018-2023). Augmenting requirement for animal breeders is estimated to favor the market growth. DNA sequencing is referred to as a technology where several DNA strands are sequenced through massive parallelization. It involves both Sanger’s and non-Sanger’s method of sequencing. The arrangement of the four nucleotide bases such as Cytosine, Guanine, Thymine, and Adenine can be identified with the help of several sequencing techniques available in the market. DNA sequencing comprises information associated with the IQ level of the human beings and genetically determined illness.

DNA Sequencing Market Potential and Pitfalls

The accelerating adoption of precision medicine along with the augmenting use of applications such as forensic biology, biotechnology, molecular biology, and virology are considered to foster the DNA sequencing market throughout the assessment period. With the increasing investment in research and development activities, the market is anticipated to gain prominence across the globe. The enzymic method for DNA sequencing has been extensively used for genomic research. As exact results were obtained during the process, the demand for DNA sequencing has increased to a large extent. The demand has further triggered the development of the second-generation sequencing method. Additional factors gearing up the market growth are the rising requirement for animal breeders and plant production, rising R&D activities, technological advancements, growth in the liquid biopsy applications, and increasing incidences of cancer.

Moreover, increased use of genome mapping programs is predicted to boost the market growth. The increasing demand for inexpensive, accurate, and fast DNA sequencing data has resulted in the advent of a new generation of sequencing technologies. Continuous changes in technologies coupled with the creation of new opportunities are some of the other factors likely to attract market players to the industry, thereby resulting in the market to expand.

On the contrary, lack of reimbursement policies in several nations is predicted to act as a top barrier hindering the market growth throughout the appraisal period. Moreover, concerns associated with standardization, accuracy, and legal and ethical limitations of DNA sequencing are estimated to vitiate the market growth globally.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5774

DNA Sequencing Market Competitive Dashboard

The prominent players operating the global DNA sequencing market are Myriad Genetics, Eppendorf, Hamilton Thorne Biosciences, General Electric Company, Life Technologies, Roche Holdings AG, Siemens Healthineers GmbH, Agilent Technologies Inc., Perkin Elmer, Beckman Coulter, Genia Corporation, Bayer Corporation, Siemens AG, Koninklijke Philips N.V., Tecan, Illumina, Deep Genomics Inc., Illumina, Oxford Nanopore Technologies, Pacific Biosciences, Johnson & Johnson, Thermo Scientific, and others.

Global DNA Sequencing Market: Segmental Analysis

The global DNA sequencing market has been segmented on the basis of product, type, application, technology, and end-users.

By mode of type, the global DNA sequencing market has been segmented into workflow products and instruments and consumables services.

By mode of product, the global DNA sequencing market has been segmented into sequencing instruments and consumables and sequencing services. Among these, the sequencing services segment is likely to witness the major share owing to its high demand globally. Due to the long-time duration taken to complete the sequencing and high-cost of sequencing instruments are encouraging the pharmaceutical companies to outsource DNA sequencing services, which is contributing to the growth of the segment.

By mode of technology, the global DNA sequencing market has been segmented into pyrosequencing, semiconductor sequencing, single-molecule real-time sequencing (SMRT), sequencing by synthesis, sequencing by ligation (SBL), and others.

By mode of application, the global DNA sequencing market has been segmented into agriculture and animal research, diagnostics, personalized medicine, biomarker discovery, drug discovery, and others.

By mode of end-users, the global DNA sequencing market has been segmented into biotechnology and pharmaceutical companies, research centers and government institutes and academia, clinics and hospitals, and others.

DNA Sequencing Market Regional Insights

Geographically, the DNA sequencing market span across regions namely, Europe, North America, Asia-Pacific, and the Middle East and Africa.

Considering the global scenario, the North American region is predicted to dominate the DNA sequencing market and is likely to retain its dominance in the coming years. The growth is credited to the increasing incidences of cancer among the geriatric population, the presence of market giants, and developed innovation ecology in this region.

The European region is considered to experience a significant growth rate throughout the appraisal period owing to the growing incidences of the geriatric population suffering from cancer, efficient reimbursement policies, and sedentary lifestyles.

The Asia Pacific region is presumed to show high potential in the global market due to increasing awareness regarding DNA sequencing and its applications. The region is also predicted to experience a fast growth rate owing to the extensive use of DNA sequencing technologies and its development.

On the other hand, the Middle East & Africa is likely to occupy the lowest market share owing to the poor medical facilities and lack of advanced technology in the developing nations in this region.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/dna-sequencing-market-5774

DNA Sequencing Industry Updates

February 12, 2019: The advent of a new DNA sequencing technique has allowed scientists to track genetic disorders in individual cancer cells. A tumor’s life history can be reconstructed for the first time and also how an error in a cell’s DNA has resulted in uncontrollable growth of a tumor. The latest technology will enable the doctors to get an understanding of how specific cancer has evolved, and personalized treatment for every patient will be made for an effective and successful result.

Healthcare Electronic Data Interchange (EDI) Market Synopsis

Market Research Future (MRFR) asserts that the global healthcare electronic data interchange (EDI) market is slated to register 8.8% CAGR during the forecast period (2018-2023). The growing need to curb healthcare costs is predicted to drive the market growth globally. Electronic data interchange is referred to as a concept of electronic business communication which enables the interchange of computer-processable electronic healthcare data in the form of a user-friendly format. The data can be interchanged among healthcare professionals, healthcare institutions, and patients. EDI finds applications in medical and dental patient database management, insurance and reimbursement data management, and regulatory data management and clinical trials.

Healthcare Electronic Data Interchange (EDI) Market Potential and Pitfalls

The healthcare electronic data interchange is gradually stealing the limelight with its augmenting adoption for performance management and operational intelligence. EDI healthcare transactions enable the elimination of paper trials and digitize all the transactions which further leads to lower handling costs of the processing healthcare documents. As per the estimations of the Workgroup for Electronic Data Interchange, the healthcare players can generate savings of USD 1 per claim for health plans, USD 0.86 for hospitals, USD 1.49 for physicians, and USD 0.83 for others, with the help of EDI. Such factors are considered to create opportunities for the market growth. The market will experience a sturdy growth owing to factors such as rising demand to curb the cost of healthcare and growing support from the government for healthcare IT projects. Also, with the growing adoption of EDI software by the pharmaceutical companies, benefits associated with the adoption of EDI such as cost savings, standardization, faster processing, and improved productivity, and implementation of favorable funding policies, the market is likely to flourish.

On the contrary, concerns related to data security, the high cost of implementation of EDI software, and the hesitance to switch from conventional techniques are some of the top barriers considered to curb the market growth throughout the appraisal period. Despite such hiccups, the utilization of EDI offers affordable solutions for the medium-sized as well as small-sized healthcare providers along with improved flexibility and scalability, thereby triggering its demand across the globe.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7338

Global Healthcare Electronic Data Interchange (EDI) Market: Segmental Analysis

The global healthcare electronic data interchange (EDI) market has been segmented on the basis of transaction, delivery mode, component, and end user.

By mode of component, the global healthcare electronic data interchange (EDI) market has been segmented into services and software. Among these, the services segment accounts for a significant share owing to the increased complexity coupled with the scale of EDI solutions as they need extensive training programs.

By mode of delivery, the global healthcare electronic data interchange (EDI) market has been segmented into EDI value-added network (VAN), web and cloud-based EDI, mobile EDI, and direct (Point-to-Point) EDI. Among these, the web & cloud-based EDI segment is considered to occupy a significant share owing to the non-requirement of software installations and low cost of web and cloud-based EDI.

By mode of transaction, the global healthcare electronic data interchange (EDI) market has been segmented into eligibility inquiry and response, claims & encounters and payment & remittance advance, claim status and response, claim attachments, referral certification and authorization, and enrollments.

By mode of end-users, the global healthcare electronic data interchange (EDI) market has been segmented into healthcare providers, healthcare payers, pharmaceutical & medical device industries, and others. Among these, the healthcare payers segment is considered to occupy the largest market share due to the increased adoption of EDI for financial management by the clinicians and physicians.

Healthcare Electronic Data Interchange (EDI) Market Regional Insights

Geographically, the healthcare electronic data interchange (EDI) market span across regions namely, Europe, America, Asia-Pacific, and the Middle East & Africa.

Considering the global scenario, the healthcare electronic data interchange (EDI) market is dominated by the American region due to the increasing expenditure on healthcare. With the growing participation of market players coupled with the technological advancements in the EDI software, the market is likely to flourish. For instance, PLEXIS Healthcare Systems had announced the expansion of EDI services with the formal launch of Ignite EDI back in 2016.

The European region is considered to occupy the second-largest share and is likely to retain its growth in the coming years. The growth is credited to the favorable policy implementation coupled with the rising funding from the government.

On the other hand, Asia Pacific is likely to expand at the fastest CAGR due to the surging expenditure on information technology in this region. As per the India Brand Equity Foundation, spending on IT in India is likely to reach USD 87.1 billion and rise over 9% in 2018.

Healthcare Electronic Data Interchange (EDI) Industry Updates

August 16, 2018: A leader in the healthcare technology solutions and products has recently partnered with the AWS in order to host HL7 managed services and HIPAAS healthcare EDI. They have announced to migrate the legacy workloads for their customers and also create a secure cloud-based solution on AWS for the healthcare sector.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/healthcare-electronic-data-interchange-market-7338

Competitive Dashboard

The prominent players operating in the healthcare electronic data interchange (EDI) market comprises McKesson Corporation, ZirMed Inc., Schreiner Group, GE Healthcare, Passport Health Communications, Emdeon Inc., Siemens Healthineers, The SSI Group LLC, HealthFusion, Optum Inc., Allscripts Healthcare Solutions Inc., Cognizant, Experian Information Solutions Inc., and others.

Healthcare CRM Market Outlook

Healthcare CRM (customer relationship management) is a software that allows the interaction between patients and healthcare organization, acting as a catalyst in the process of communication and care delivery. Using this technology (CRM software), healthcare organizations can arrange customer data and interactions to achieve simplification of business processes, such as customer service & support, marketing, sales, and digital marketing, etc.

In a way, CRM software helps healthcare companies to stay connected with their customers and thereby improve profitability, streamlining the work processes. Over the last couple of decades, the global healthcare CRM market is growing pervasively, witnessing a huge uptake of CRM software in the growing number of healthcare companies. Moreover, factors such as the proliferation of Cloud deployment and the increasing deployment of cloud-based CRM modules escalate the market on the global platform.

Acknowledging the prominence and value, the market is gaining at present, Market Research Future (MRFR) in its recently published analysis asserts that the global healthcare CRM market will register a CAGR of 13.8% throughout the forecast period (2018-2023), recording a fabulous growth by the end of 2023. In the year 2017, the market had valued at USD 7.9 BN.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7324

The growing number of healthcare centers and advantages that CRM software provides are some of the key factors predominantly propelling the growth of the market. Besides, increasing use of web-based interfaces and social computing are escalating the market growth to ascending levels.  Additional factors such as the increasing focus on patient engagement and rising demand for structured data and automation in healthcare organization are acting as major tailwinds that are driving the growth of this market.

On the other hand, factors such as the high cost and complexity of CRM and concerns regarding data security act as major headwinds that hurdle the growth of the market.  Nevertheless, factors such as technological advancement in the field of communication and Information Technology (IT) and the proliferation of cloud technology are expected to support the growth of the market.

Global Healthcare CRM Market   - Segments

For ease of understanding, the market has been segmented into five key dynamics: 

By Component: Software and Services.

By Deployment Model: On-premise Model and Web/Cloud-based Model.

By Functionality: Customer Service & Support, Marketing, Sales, Digital and Marketing among others.

By End-user: Healthcare Providers, Life science Industry, and Healthcare Payers among others.

By Regions: North America, Asia Pacific, Europe, and the Rest-of-the-World. 

Global Healthcare CRM Market   - Regional Analysis

The North American region, heading with the government initiatives and policies to encourage the adoption of healthcare IT accounts for the leading market for healthcare CRM, globally.  Factors such as the advancements in technologies and growing uptake electronic health record (EHR), and the rise in the investments in Healthcare Information Technology (HCIT) are favoring the implementation of CRM solutions and are expected to support the market to retain its dominance throughout the forecast period.

The healthcare CRM market in the European region accounts for the second-largest market, globally. The presence of well-established HC infrastructures and matured players in the region is acting as a key driving force, allowing the favorable environment for technological developments.

The market is projected to witness a higher adoption of healthcare CRM tools owing to the excellent network and IT development in the region. Additionally, factors such as the growing focus of CRM providers on developing and commercializing Artificial Intelligence (AI) and analytics-powered advanced CRM are driving this market.

The Asia Pacific healthcare CRM market is rapidly emerging as a profitable market, globally. Proliferating healthcare sector and the increasing number of healthcare facilities in the rapidly developing countries such as China, Japan, Korea, and India substantiate the market growth, augmenting the demand for deployment of healthcare CRM software. Simultaneously, improving the quality of healthcare systems, growing medical tourism market, and increasing government initiatives are increasing the size of the market.

The Indian government is promoting the Digital India Program with a vision to transform the nation into a digitally empowered economy which in turn, will pose India as a prominent market for healthcare quality management. Companies operating in the APAC region will benefit from the flexible policies of the government as well as the expanding digital market that will have a significant impact on the healthcare community. 

Healthcare CRM Market – Competitive Analysis

The healthcare CRM market appears fiercely competitive with the presence of several large and small players. The key strategies traced from the analysis of recent market developments include agreement & partnership, product launch, acquisition, and expansion. 

International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of technology portfolios, differentiation, quality, and pricing.

These key players are employing strategies of creating alliances with e-commerce partners with strong local players in regions such as APEJ and Western Europe to consolidate their position. Growth in terms of innovations/ technologies in the market is also expected to create strong investment opportunities for global players.

Major Players:

Key players leading the global healthcare CRM market include Com, Inc., Oracle, Microsoft, IBM, SAP SE, Influence Health, Inc., Accenture Healthgrades, Infor, Inc., Amdocs Ltd., Anthelio Healthcare Solutions, AllScripts Healthcare Solutions Inc., and NetSuite among others.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/healthcare-crm-market-7324

Industry/ Innovation/ Related News:

March 05, 2019 ---- The Wasatch Group (the US), a multi-billion-dollar entrepreneurial company operating in a diversified portfolio on a national level announced the acquisition of MarketStar (the US), a leading firm in outsourced sales acceleration services and the part of the DAS Group of Companies which is a global group of marketing services companies following marketing disciplines including specialty, PR, and healthcare CRM among others.

The acquisition is the result of DAS Group's is consistent with its strategic plan and investment priorities and is continuing evaluation of its portfolio of businesses. It further accelerates growth for DAS Group and increases investments to serve their clients better and positions them for the future.

Antifungal Treatment Market Overview

Global antifungal treatment market is expected to register a CAGR of 4.61% and attain a valuation of USD 19,558.0 Mn by the end of the forecast period of 2017-2023, projects Market Research Future (MRFR) in a detailed study. 

Surging prevalence of fungal infections is the prime drive behind the growth of the global antifungal treatment market. People across the globe are afflicted by severe fungal infections such as cryptococcosis, candidiasis, aspergillosis, and pneumocystosis which can be life-threatening. Fungal infections have risen dramatically in recent years which has generated high demand for diagnosis and treatment consequently boosting the growth of the global antifungal treatment market. 

Motivated by the alarming rise in fungal infections and a strong need for effective antifungal compounds, there has been extensive research & development on new antifungal compounds have resulted in the development of new antifungal agents. This coupled with increasing government support for R&D activities create a supportive dais for the growth of the global antifungal treatment market. 

Various programs have been initiated across the globe to reduce fungal illness and deaths associated with fungal diseases worldwide and to educate healthcare professionals regarding the same which has further propelled the growth of the global antifungal treatment market. 

A rise in the number of FDA approvals for antifungal drugs is expected to lead growth in the global antifungal treatment market. Other driving factors include the availability of new drugs, growing awareness regarding the side effects of traditional remedies and rise in geriatric population. 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/1628

Antifungal Treatment Market Segmentation

The global antifungal treatment market has been segmented based on drug class, therapeutic indication, pathogen, and end user. 

By drug class, the global antifungal treatment market has been segmented into azoles, echinocandins, polyenes, pyrimidines, allylamines, and others drugs. The Azoles segment held the largest market share in 2016.  

By therapeutic indication, the global antifungal treatment market has been segmented into systemic, coccidioidomycosis, candidiasis, and cryptococcosis. The systemic segment was the largest segment in 2016. 

By pathogen, the global antifungal treatment market has been segmented into Candida, Cryptococcus, Coccidioides immitis, Aspergillus, Zygomycetes, Trichophyton, and others. 

By end user, the global antifungal treatment market has been segmented into hospitals & clinics, dermatology clinics, and other users. 

Antifungal Treatment Market Regional Analysis

The Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA) are the key markets for antifungal treatment. 

The Americas is account for the lion's share of the global antifungal treatment market driven by the widespread prevalence of fungal infections in the region, high healthcare expenditure, and availability of advanced treatment options. 

Europe is the second largest market for antifungal treatment and is expected to grow significantly over the forecast period. High investment in R&D activities, availability of skilled medical professionals, increasing healthcare expenditure and surging prevalence of fungal diseases in the region. 

Antifungal Treatment Market Competitive Landscape

The key players in the global antifungal treatment market include Novartis AG (Switzerland), Merck & Co., Inc. (U.S), Pfizer Inc. (U.S), Bayer AG (Germany), Astellas (Japan), and Sanofi (France). 

Antifungal Treatment Industry Updates

In December 2018, The US Food and Drug Administration (FDA) approved SUBA-itraconazole (Tolsura), an antifungal indicated for the treatment of systemic fungal infections. The SUBA-itraconazole can be used in the treatment of blastomycosis, aspergillosis, and histoplasmosis. 

In January 2019, F2G Ltd, a biotech company focused on developing therapies for life-threatening fungal infections, raised funding of EUR 24 Million loans from the European Investment Bank (EIB). The company also raised funding from life science investor Morningside Venture Investments Ltd. (Morningside). The funding would be utilized by the company to expedite its worldwide Phase 2b study on invasive fungal infections.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/antifungal-treatment-market-1628

Veterinary CBD Market Overview

Global veterinary CBD market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 36.3%, surpassing a valuation of USD 17.345 billion during the forecast period till 2025.

CBD pet products possess anti-inflammation and anti-anxiety properties, which are the primary growth stimulants of the veterinary CBD market. The market is estimated to garner an impressive CAGR, mainly due to the surging number of household pets and mounting demand for humane practices in livestock management. The easing restrictions governing the utilization of CBD products in order to treat several ailments are estimated to propel the market growth in the coming years. As the pet care market globally seems to witness a never-ending rise, CBD infused products will garner revenues. The surging adoption of pets and soaring demand for premium care products are likely to encourage the market growth across the globe.

On the contrary, the unclear regulatory environment for the utilization of CBD products, coupled with the manufacturing of source product are estimated to deter the market growth in the foreseeable future.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/veterinary-cbd-market-8138

Global Veterinary CBD Market: Segmental Analysis

The veterinary CBD market has been segmented on the basis of source, product, and distribution channel.

By source, the veterinary CBD market is segmented into marijuana-derived and hemp-derived. Of these, marijuana-derived veterinary CBD is considered completely legal in South Africa, Canada, and a few US states. It is one of the top raw materials for CBD products owing to the potency of the THC. Several countries are likely to legalize marijuana in the coming years due to its medicinal values.

The product segment includes therapeutic-grade, food-grade, and personal care. Of these, the therapeutic-grade is estimated to be the fastest-growing segment owing to the rising support for these products, especially by the veterinarians. Also, the rising consumer concern for the mental wellbeing of pets has influenced the market growth in the segment.

The distribution channel is segmented into retail pharmacies, e-commerce websites, veterinary clinics, and others. Of these, the e-commerce websites channels are considered one of the best distribution channels for these products due to the current boom in e-commerce and easy availability of these products online.

Regional Frontiers

Geographically, the veterinary CBD market spans across the Asia Pacific, America, Europe, and the Middle East & Africa.

Considering the global scenario, America is estimated to lead the veterinary CBD market owing to the legislative allowances for marijuana, coupled with the large-scale infrastructure support for new industries. The veterinary market is concentrated in this region, but there is significant untapped potential in other regions as well, mainly due to the surging number of pets and increased spending on pets.

Europe is an emerging market for Pet CBD. Increased focus on pet health and a well-established tradition for implementation and research has made the region a strong contender to the market in North America.

The Asia Pacific boasts the highest number of livestock and pets, and the regional market is presently limited by regulatory norms and high preference for traditional medical practices. The region promises aggressive market growth as it is the largest producer of hemp and has a recorded history of medicinal marijuana use.

Industry Updates

August 2019: A global leading hemp and cannabis wellness brand for pets, True Leaf Brands Inc. has recently declared that the company has launched its veterinarian-formulated, cannabidiol (CBD) supplements, especially for dogs at SuperZoo 2019.

Competitive Dashboard

The top players operating in the veterinary CBD market include HolistaPet (US), Honest Paws (US), Canna-Pet (US), HempMy Pet (US), Fomo Bones (US), Joy Organics (US), Green Roads of Florida (US), Pet Releaf (US), and Wet Noses (US).

Healthcare Biometrics Market Insights

Digitization, technological enablement, and automation like factors have created deep penetration in the industries and are rapidly influencing the healthcare sector. The adoption of the latest technologies is driven by parameters such as efficiency optimization, cost control, and meet the long-term objectives. Market Research Future anticipated that the global healthcare biometrics market will touch the mark of USD 5.6 billion at the CAGR of 22.3% during the forecast period, 2016-2022.

Biometrics technology is swiftly venturing in the healthcare sector specifically to retrieve the medical data of patients through fingerprint scanners, palm vein readers, facial recognition solutions, iris scanners, or mobile link authentication for smooth treatment and transparent transaction.

Some of the drivers driving the growth for the global healthcare biometrics market are the surge in demand for high-tech and authentic data tracking technologies and the rise in healthcare service awareness with favorable reimbursement policies. Growing patient pool and rise in healthcare expenditure is marking a radical shift towards digitization owing to the efficient and precise results. However, these trends are expected to help the global healthcare biometrics market during the forecast period.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/2450

Healthcare Biometrics Market Segmentation

The global healthcare biometrics market is broadly segmented on the basis of application, technology, and end-users.

The technology segment of the global healthcare biometrics market is bifurcated into face recognition, fingerprint recognition, palm geometry recognition, iris recognition, vein recognition, and others.

The application, the global healthcare biometrics market, is classified into medical record management, patient identification, patient monitoring, data security, and others. The patient monitoring segment is anticipated to spur swiftly due to escalating demand for superior patient care service.

The global healthcare biometrics market is also diversified into the end-user, such as research laboratories, hospitals, healthcare institutes, and others. The major contributor to the global market around the globe is the hospital segment owing increased adoption of biometric systems.

Healthcare Biometrics Market Regional Insights

Growing demand for sophisticated healthcare facilities and regulatory needs are some of the factors encouraging the growth of global market growth. North America is holding a majority of the market share owing to well-established digital sector and constant innovation driven by high acceptance rate. The insurance sector is also backing the growth trend of the market. Due to dominance in various service offerings such as medical record management, patient identification, patient monitoring, data security, and authentication solutions, the US lead the global market.

The European healthcare biometrics market is set to emerge as the most lucrative market as various industry giants are eyeing the region for expansion to increase production capacity. The rise in disposable income and booming economies with end-users looking for solutions to make the healthcare monitoring simple are some of the key factors driving the growth of the global market.

The Asia Pacific market is predicted see a swift growth owing to the growing demand for healthcare services supported by growing patient population. The scope of expansion in various untapped areas in the region might create worthwhile opportunities in the market and encourage growth.

Healthcare Biometrics Market Key Players

The leading players in the global healthcare biometrics market are more inclined towards developing a well-defined and transparent treatment and diagnostic process to mark their position highest in the graph. These leading players include NEC Corporation, Crossmatch Technologies Inc., Bio-Key International, Morpho (A Subsidiary of Safran SA), Integrated Biometrics, Imprivata Inc., Fujitsu Limited, 3M Cogent Inc.

Healthcare Biometrics Market Recent Updates

Nuance Communications, a voice processing and biometrics service provider, has alliance with Microsoft to renovate the healthcare delivery with ambient clinical intelligence to design the futuristic examination room, where clinical writing will be auto generated. According to the announcement the advancement in the technology would help to captivate the doctor-patient experience.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/Healthcare-biometrics-market-2450

Global Medical Holography Market Research Report: Information by Product (Holographic Displays, Holography Microscopes, Holographic Prints, Holography Software, and Holoscopes), Application [Medical Imaging (Opthalmology, Dentistry, Urology, Orthopedics, and Others), Medical Education, and Biomedical Research], End User (Hospitals and Clinics, Academic Medical Centers, Research Laboratories, and Pharmaceutical and Biotechnology Companies), and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2025

Medical Holography Market Overview

Holography is handled to record and show three-dimensional data without the utilization of the focal points, along these lines it is of monstrous use and makes enormous conceivable outcomes of uses over the field of science, building, illustrations just as expressions. The optical components in holography play out the capacity of mirrors, focal points, gratings, and mixes of them. There is a scope of medical sicknesses where the intricacy of the infections and organs dysfunctionality raises the requirement for legitimate representation of the influenced territory, where the utilization of holographic gadgets assumes a critical job. With the development of high interest in medicinal services offices, mechanical headways in careful rooms, just as, developing requirement for customized drugs, drives the development of holography market in the medical field. In any case, the elements, for example, constrained consumption by government offices and human services offices in emergency clinics of low and center pay nations, obstruct the foundation of holography utilization in strength focuses of a medical clinic. Additionally, the lack of skilled experts is among the significant restriction for holography utilization in the medical space.

A few colleges crosswise over Europe and the United States, the computer generated experience multi-dimensional image based useful investigations and clarifications are evaluated to be progressively embraced as a genuine piece of medical training. With the advances in lasers and optics capacity in the medical field, the development in circulation of these holographic gadgets is required to rise essentially over an enormous number of medical instruction offices particularly over the created markets, trailed by the relentless selection rate in developing markets of the world. With enormous use conceivable outcomes to improve the anatomical structures seeing, for example, the structure of veins over numerous organs are required to expand the appropriation pace of these gadgets in medical training field.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/1519

Competitive Analysis:

The key players operating in the global medical holography market include Phase Holographic Imaging AB, Holoxica Limited, Nanolive SA, Echopixel, Zebra Imaging, EON Reality, Inc., RealView Imaging Ltd., Mach7 Technologies Limited, Lyncee Tec., and zSpace, Inc. The major players in the market are focusing on technological advancements coupled with improving the material quality used in manufacturing sutures and better treatment of the injury site.

Segmentation:

The medical holography market is segmented based on type, medical application, and region.

In terms of type, the global medical holography market is categorized into reflection hologram, hybrid hologram, transmission hologram, and others.

Based on the medical application, the market is segmented into X-ray holography, ophthalmology, endoscopic holography, dentistry, and other.

Regional Analysis:

Based on the region, the market is segmented into Europe, the Americas, Asia Pacific, the Rest of the World (RoW). Of these, the Americas are estimated hold strong position in the medical holography market owing to United States and Canada are exceptionally best in class as far as new innovation acquisition, early discharge in the market, better repayment strategies and home to home office of a few medical gadgets and pharmaceutical organizations.

Since, there is an enormous arrangement of the worldwide populace which additionally approach these nations for outstanding amongst other medical medications, the brisk selection of new innovation, for example, medical holography is of numerous points of interest over all end clients. The need to facilitate the treatment and strategies has developed fundamentally in recent decade which has offered ascend to a few R&D speculations and adventure accomplices financing to new companies which drive the medical holography market in North America. Europe is estimated to stand in the second leading position in the medical holography market owing  to wide acceptance in the region.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/medical-holography-market-1519

Mucormycosis Market – Overview

The rise in the causative factor for mucormycosis and poor detection rate has contributed to the development of the Mucormycosis Market. Reports that gauge the healthcare industry have been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is expected to garner a CAGR of 7.3% approx, in the upcoming period.

The declining overall health and well-being standards globally have induced the development of the mucormycosis market. Also, most of the population base affected by mucormycosis has a low immunity level and a limited tolerance level to the treatments that are subsequently administered. The market is expected to gain traction in the upcoming period due to the increasing incidence of immunological diseases around the world.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5440

Segmental Analysis

The segmental analysis of the mucormycosis is carried out on the basis of diagnosis, species, treatment, region, and end-users. Based on the species, the mucormycosis market is segmented into Rhizomucor, Rhizopus, Apophysomyces, Cunninghamella, Lichtheimia, Saksenaea, and Mucor, and others. Based on the diagnosis, the mucormycosis market is segmented into Magnetic resonance imaging (MRI), Computed Tomography (CT), tissue biopsy, and others. The segmentation of the mucormycosis market by treatment comprises of antifungal drugs, surgery, amphotericin B therapy, and others. The end-user segmentation of the mucormycosis market comprises of medical institutes, hospitals & clinics, research organization, and others. By regions, the mucormycosis market consists of Europe, the Americas, Asia Pacific, and the Middle East and Africa.

Detailed Regional Analysis     

The regional evaluation of the mucormycosis market covers regions namely Europe, the Americas, Asia Pacific, and the Middle East and Africa. The Americas region dominates the mucormycosis market due to a strong healthcare sector and the presence of an immense patient population for mucormycosis. Due to the scarcity of limited oral preparation in the market, the progress and licensing of new drugs in the market is a big opening for the advance of the market throughout the forecasted period. The European region is the subsequent major market for mucormycosis due to the development in the technology of surgical devices along with the increasing incidence of fungal infections among the patients. The rising percentage of diabetes mellitus population mostly in the developed countries of the European region is anticipated to open up new prospects for the mucormycosis market. The Asia Pacific region is the top mounting region for antifungal treatment owing to the growing prevalence of HIV and the presence of vast untapped growth chances for the expansion of the market.

Competitive Analysis

The advancement of the market is projected to capture amplified impetus in the coming years chiefly due to the incidence of contributory government plans. The escalated turnaround in the market is likely to set off new openings for the development of the market. The enhancement in different domestic economies is projected to encourage the progress of the market in the impending period. The ease in accessing key planned opportunities important to consequent stabilization of inflation is projected to generate a promising option for development in the approaching years. In the approaching years, the control exerted by fairly high-income level nations around the world and the likely gains observed towards a few of the currencies around the world is projected to strengthen the fruition of the market in the forecast period. A significant climb in the number of backers in the market is expected to craft an advantageous state of affairs for the evolution of the market in the projected period.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/mucormycosis-market-5440

The significant competitors in the mucormycosis market are Biocon Limited (India),  Cadila Pharmaceuticals Limited (India), Novartis AG (Switerzland), Abbott Laboratories (U.S.), Myers Squibb (U.S.),  F. Hoffman La Roche (Switerzland),   Merck Sharp and Dohme (U.S.), Sanofi (France), Mylan Labs (U.S.), Johnson & Johnson (U.S.), Bristol Bayer AG (Germany), Lonza Group (Switerzland), Pfizer Inc. (U.S.), Gilead Sciences (U.S.), and others.

RSV Diagnostics Market Highlights

The latest report by Market Research Future (MRFR) states that the RSV Diagnostics Market is all set to gain substantial traction by accruing gigantic revenues by 2023. In addition, it is on track to surge at a CAGR of 10.4 % during the forecast period (2018–2023).

RSV Diagnostics Market Drivers and Top Restraints

The document named “Reducing Neonatal Mortality and Morbidity in Latin America And the Caribbean, An Interagency Strategic Consensus” states that almost 400,000 children under the age of five die due to infections that could have been prevented. This has attracted the focus of various health agencies that are striving to get a hold of the issue. For instance, Latin American Center for Perinatology and Pan America Health Organization (PAHO) have diverted their focus in the direction of educating the parents to fight against possible infections, promoting the growth of the RSV diagnostics market in the process.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6217

The rising incidence rate of respiratory infections has done wonders for the market and is bound to surge at a significant rate in the coming years. with the growth in the incidences of chronic diseases around the world, there is bound to be an increase in the case of respiratory infections. This is going to have a definite positive impact on the demand for testing of infectious diseases like RSV. The deaths among neonates owing to these infections can be prevented when timely diagnosis and subsequent treatment is provided. Thus, the growing awareness regarding this factor is set to enhance the growth of the RSV diagnostics market in the years ahead.

The boost in the number of product launches across the globe will be one of the primary reasons fueling the growth of the respiratory syncytial virus diagnostics market in the forthcoming years. On that note, various diagnostics companies are keen on expanding their revenue with the development and introduction of the latest RSV diagnostics products in the market. These sophisticated diagnostic products are known to be highly efficient and reduce the time needed for the diagnosis.

The Rising Number of OEMs to be the Key Trend in the Global Market

The growth in the number of original equipment manufacturers (OEMs) is on its way to become a popular trend in the worldwide RSV diagnostics market in the near future. OEMs like Thermo Fisher Scientific and Sekisui Diagnostics are one of the leading manufacturers that offer RSV diagnostics.

There has been a rise in the number of combination products like drug delivery and smart devices, which is prompting the OEMs to work in conjunction with the contract manufacturing organizations (CMOs), making way for a number of new companies to gain entry into the market. As a result, there has been an increase in the product range required for diagnosing RSV. 

RSV Diagnostics Market Segmentation

The global RSV diagnostics market has been segmented based on product, method, and end-user.

Depending on the type of product, the market has been classified into kits and assays, instruments, and other products.

Method-wise, the global RSV diagnostics market has been considered for molecular diagnostics, rapid antigen detection test, gel microdroplets, flow cytometry, and others. Furthermore, the rapid antigen detection tests are sub-segmented into enzyme-linked immunosorbent assays, immunofluorescence assays, and other rapid antigen detection tests. The other type of rapid antigen detection tests can be segmented into chromatographic immunoassays and optical immunoassays.

The end-users mentioned in the report include hospitals and clinics, clinical laboratories, home care, and others.

RSV Diagnostics Market Regional Outlook

The global RSV diagnostics market is segmented into the regional markets of the Americas, Asia Pacific, Europe, as well as the Middle East & Africa.

The Americas will be the most lucrative market for RSV diagnostics on account of the rising incidences of RSV, growing healthcare expenditure and technological advancements in molecular diagnostics. As per the Centers for Disease Control and Prevention, over 57,000 children younger than five years old are hospitalized owing to RSV infection every year, in the United States (U.S). In order to bring down this abysmal number, various initiatives and programs are being introduced in the region, which means that the market will be doing excellent business in the region in the years to come.

Meanwhile, Europe has landed the second spot in the global RSV diagnostics market, with factors like increasing automation in vitro diagnostics, rising occurrence of RSV diseases, and surging funding offered by the government backing the said growth. Considering the current status of the region, the data furnished by the University of Oxford states that more than 30,000 babies and children less than five years of age are expected to be hospitalized every year owing to RSV.

The RSV diagnostics market in Asia Pacific can be broken down into smaller markets in the countries of India, Japan, China, Republic of Korea, Australia and the rest of the region. The regional market is touted to be the fastest-growing globally as a result of the rise in the infectious disease which includes the RSV infection. Also, the increasing healthcare expenditure coupled with the surge in the demand for RSV disease diagnosis has taken the market to higher levels in the past few years. In addition, countries like India, China, and Japan are deemed to be growing at the fastest rate in the region with the expanding healthcare systems along with the growing government initiatives backing up these markets.

Showcasing a rather sluggish growth rate in the global market is the region of the Middle East and Africa, which despite various restraints holds immense potential. The market shows promise, with the support of various factors including the increasing awareness and high investments by private industry participants combined with the increasing incidences of RSV in children in the region.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/rsv-diagnostics-market-6217

Key Vendors

Bio-Rad Laboratories Inc., Abbott, F. Hoffman-La Roche Ltd., Danaher Corporation, Quest Diagnostics, Biocartis, Luminex, Hologic, Fast Track Diagnostics, Biomerieux, Becton, Dickinson, and Company (BD), Alere, Inc., Quidel Corporation, Thermo Fisher Scientific are among some of the top most companies in the RSV diagnostics market.

Latest News

May 2019

SpeeDx Pty. Ltd. has gotten the clearance from the Australian Therapeutic Goods Administration (TGA) of their PlexPCR RespiVirus test. It makes use of the PlexPCR technology for detecting 11 types of pathogens known for causing viral respiratory-illnesses. In addition, this test also lets the laboratories process a greater number of samples in a limited period of shift compared to a conventional in-house test.

Surgical Stapler Market Overview:

Surgical stapler market has been growing steadily ever since the technique was enhanced to be efficiently used in the surgical scenario in the 1970s. stainless steel staples are used due to their various advantages that include quick procedure, strong wound closure and minimal tissue reaction. Various surgical procedures such as gastrointestinal, thoracic, gynecologic as well as bariatric surgeries for weight loss have made good utilization of surgical staplers.

Surgical staplers market has witnessed increased interest due to the increasing demand made on surgeons. Most often surgeons are pressed for time which leads to physician burnout. Stapling can usually be performed quicker than suturing and is a preferred means of wound closure when it comes to mass casualties where trauma care must be immediate and effective. Surgical staples are preferred by first responders in cases of emergencies as wound closure to stop the bleeding is crucial in such cases. Data collected in the U.S. estimates that nearly 60,000 Americans die from blood loss and physical trauma leads to as many as 1.5 million deaths due to hemorrhage.

Increasing demand for weight loss surgeries has also added a potential boost to the surgical staples market. Stomach stapling or bariatric surgery is one of the most common types of surgeries for controlling obesity. Gastric stapling surgery is a means of dealing with morbid obesity or to help in weight loss for people who are affected with diabetes, sleep apnea and cardiovascular problems. Diets and exercise are not found to be very effective in people with a BMI of more than 40 and bariatric surgery, which drastically reduces the size of a person’s stomach has been found to be one of the most viable and affordable options.

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/6382

Some of the factors can deter surgical staples market growth include high cost of the procedure as well as lack of awareness. In some cases, staplers had been known to have become embedded in the skin, thus making removal difficult. Recently ripples were caused in the surgical stapler market by the news that Johnson’s and Johnson’s subsidiary Ethicon recalled its 60mm staplers in various European countries due to reports of injuries caused by malformed staples. However, regulatory bodies like the FDA are initiating awareness drives for the correct and safe use of surgical staples which is expected to keep such mishaps at bay in the future.

Surgical Stapler Market Segmentation:

Surgical stapler market is segmented on the basis of type, application, product and end-users.

By type, surgical stapler market is subdivided in to disposable and reusable surgical staplers.

By application surgical stapler market is segmented into general surgery, abdominal and pelvic surgery, orthopedic surgery, cardiac and thoracic surgery and others.

By product, the surgical stapler market is segmented into powered surgical staplers and manual surgical staplers.

By end-users the market is divided into hospitals, clinics and ambulatory surgical centers.

Surgical Stapler Market Regional Analysis:

When the market is analyzed region-wise, North America, with its growing geriatric population and increasing number of surgical procedures that involve surgical stapling is expected to lead the surgical stapler market share. Considering the fact that obesity is rampant in the U.S. with a 2015-2016 study by National Center for Health showing that 39.8% of adult males in the country were obese, bariatric surgery is very common in the country, driving the surgical stapler market.

Europe together with North America is expected to account for 70% of the surgical stapler market during the forecast period. Adoption of advanced surgical techniques will fuel surgical stapler market trends in the region.

Asia-Pacific is expected to emerge as the region with the fastest growing share in the surgical stapler market owing to increased expenditure in healthcare, rising awareness and increasing prevalence of cardiac diseases.

Surgical Stapler Market Competitive Scenario:

Some of the participants in the surgical stapler market include Purple Surgical Inc., Smith and Nephew Plc, Ethicon US, LLC, Medtronic, CONMED Corporation, Reach Surgical, Frankenman International Limited, Stryker, B. Braun Melsungen AG, Grena Ltd, Touchstone International Medical Science Co. Ltd, Cardica Inc. and Zimmer Biomet.

Get More Information on Surgical Stapler Market Research Report – Forecast to 2023 @ https://www.marketresearchfuture.com/reports/surgical-stapler-market-6382

Surgical Stapler Industry News:

Recently, Ethicon, the subsidiary of Johnson & Johnson Medical Devices Companies, launches a powered circular stapler that is apparently the first of its kind in the surgical stapler industry. It is designed to address serious complications arising in wound closure in colorectal, thoracic and gastric surgeries. The Echelon Circular Powered Stapler, as it is called, claims to be 61% more effective that the EEA™ Stapler developed by Medtronic when it comes to reducing leaks in the staple line.

Biobanking Market Overview

Biobanking is defined as a process by which samples of bodily fluid or tissue are collected for research. The collected sample is meant to improve the doctor's understanding of health and disease. A new report on the global biobanking market, published by Market Research Future (MRFR), concludes that this market can view gains at 7.6% CAGR  between 2018 and 2023.

The most important market drivers for the global biobanking market growth are increasing applications in life sciences and increasing demand for research activities in genomics for studying various diseases. The increasing research & development (R&D) is strengthening the global biobanking market. Other market drivers that are responsible for the global biobanking market growth include increasing government as well as private funding to support the regenerative medicine research, growing penetration by market players, and increasing technical advanced devices. Today the medical sector is growing in both developed as well as developing countries. However, factors like the higher cost of automation can restrain the global biobanking market growth.

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/5967

Biobanking Market Segmentation

The global biobanking market segmentation encompasses application, end-use, product & services, sample type, and storage type. MRFR’s take on the market marks various facets of the market in-depth.

The application-based segmentation of this market covers clinical research, life science research, regenerative medicine, and others. Based on end-use, the market has been segmented into diagnostic laboratory, hospitals, research centers, and others. Based on the sample type, the market has been segmented into biological fluids, blood products, cell lines, human tissues, nucleic acids, and others. Regarding storage type, the market has been segmented into automated storage and manual storage.

The products & services segment has been segmented into consumables, equipment, services, and software. The consumables segment has been sub-segmented into analysis consumables, collection consumables, processing consumables, and storage consumables. The equipment segment has been sub-segmented into sample analysis equipment, sample processing equipment, sample transport equipment, and storage equipment. The services segment has been sub-segmented into processing services, storage services, supply services, and transport services.

Biobanking Market Regional Segmentation

A geographical outlining of the global biobanking market covers the Americas (North America & South America), Asia Pacific, Europe, and the Middle East & Africa (MEA).

The Americas is the largest regional market as North America alone has the potential of becoming a powerful regional market. Due to the advanced medical facilities being available in the USA and the presence of key market players, North America is a larger regional market segment compared to South America. In North America, other factors leading to market growth include growing investments in healthcare, the increasing number of research activities in genomics, and surging patient population suffering from chronic ailments. The USA has the presence of the largest number of hospitals-based biobanks, and increasing awareness about biobanks makes the USA the biggest country-specific market. Due to the increasing demand for cost-effective drug development can become the fastest-growing country-specific market in North America during the forecast period. In South America, the market can grow faster during the forecast period due to increasing demand for treatment options for chronic ailments and the availability of technologically advanced devices for diagnosis.

In Europe, the biobanking market is growing due to the increasing emphasis on R&D activities for improvement in diagnosis and treatment methods. The increasing expenditure in the healthcare sector by major countries in Europe is also accelerating market growth. Due to the reasons the same as in The Americas, Western Europe is a bigger market compared to Eastern Europe. Germany and the UK are the biggest revenue contributors to the European market. Other important country-specific markets in Europe are France, Italy, and Spain.

During the forecast period, the Asia Pacific region can the fastest growing regional market due to the increasing burden of chronic ailments, increasing focus on early diagnosis, the influence of western culture among the adults, the increasing environmental pollution, exposure to harmful chemicals, increasing healthcare expenditure, lifestyle changes, growing healthcare sector, and treatment of rare diseases. The presence of developing economies like China and India is also boosting the market growth as the medical sector is progressing in both countries. Other great country-specific markets in this region are Australia, Japan, and South Korea.

In the MEA region, the market can grow steadily due to the flourishing growth of the medical device sector, especially diagnostic devices. An increase in the number of healthcare facilities providing treatment for chronic conditions also boosts the market. The influential country-specific markets in this region are Kuwait, Oman, Saudi Arabia, Qatar, and the UAE.

Biobanking Market Key Players

Big players in the global biobanking market are Becton Dickinson & Company (USA), Brooks Automation Inc. (USA), Chart Industries Inc. (USA), Greiner Holding AG (Austria), Hamilton Company (USA), Merck KGaA (Germany), Panasonic Healthcare Holdings Co. Ltd. (Japan), Promega Corporation (USA), Qiagen N.V. (Germany), Tecan Trading AG (Germany), Thermo Fisher Scientific Inc. (USA), and VWR Corporation (USA).

Get More Information on Biobanking Market Research Report – Forecast to 2023 @ https://www.marketresearchfuture.com/reports/biobanking-market-5967

Biobanking Market Industry News

The Matrix Gemini Biobank Management System from Autoscribe Informatics is now offering users, greater versatility by including environmental monitoring and equipment calibration. The new system also offers maintenance monitoring capabilities. 20 AUG 2019